SEC Form 4 · accession 0001615774-16-004650
Enumeral Biomedical Holdings, Inc. · ENUM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Kevin G Sarney
Officer — Vice President of Finance
Period of report
Mar 24, 2016
Accepted (ET)
Mar 28, 2016 · 4:39 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001561551
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock Option (Right to Buy)F1 | $0.20 | Mar 24, 2016 | A | 275,000 | A | — | Mar 23, 2026 | Common Stock | 275,000 | 275,000 | D |
Explanation of responses
- F1The option vests and becomes exercisable as follows: (a) 50% of the shares underlying the option vest immediately upon grant, and (b) the remaining 50% of the shares underlying the option shall vest on June 30, 2016.